On April 18th BC PharmaCare announced that it was expanding its existing coverage of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the paediatric population only. Three long acting ADHD medications (Adderall XR, Vyvanse and Strattera) will be added under the Special Authority (SA) program. CADDRA and CADDAC along with BC medical practitioners welcome these expanded medication options for children. However, British Columbia continues to lag significantly behind other provinces by denying coverage to individuals over 19, thereby discriminating against adults with ADHD.
Read More on our Blog
May 2, 2017 Media Releases
Life inside an ADHD brain can be…unpleasant at tim... Read More
Growing up, my late father told me that I was “bor... Read More
Many of us ADHDers have heard about the analogy th... Read More
Shaming has been the name of the game for kids wit... Read More
Many parents find themselves redefining what “home... Read More
